Skip to content
LLS Learning Management
  • Home
  • Courses for…
    • Physicians
    • Pharmacists
    • Pharmacy Technicians
    • Nurse Practitioners
    • Nurses
    • Social Workers
    • Archived Education
  • Other LLS Courses
  • Login

Multiple Myeloma (MM): Diagnosis, Treatment and Side Effects Management

Home > Course > Multiple Myeloma (MM): Diagnosis, Treatment and Side Effects Management

Multiple Myeloma (MM): Diagnosis, Treatment and Side Effects Management

February 11, 2020 | By admin
0

Instructions for Credit — This activity is accredited for 1.25 continuing education credits for nurse practitioners, nurses, and social workers. Participants must attend the free webinar in its entirety, submit the online evaluation form  and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.

Please retain a copy of the certificate for your records.  For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc. at (609) 333-1693 or ndane@mlicme.org.

You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation.  

X

Please Complete Form

Accreditation and Disclosure Information

Target Audience — Nurse practitioners, nurses and oncology social workers involved in the care of patients with multiply myeloma (MM).

Course Content Level for Social Workers  — Intermediate and Advanced

Format: Non-interactive recorded webinar

Learning Objectives — At the conclusion of this program, participants will be able to:
• Describe an overview of multiple myeloma (MM)
• Identify tests used to diagnose disease and monitor treatment of MM
• Explain the overarching goals of treatment for MM
• Explain approved and emerging treatment options for MM, including stem cell transplantation, and the role of clinical trials
• Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for MM
• Describe the roles of the pharmacist, the nurse and the social worker in treating patients with MM

Provider — This activity is provided by The Leukemia & Lymphoma Society.

Continuing Education for Nurse Practitioners, Nurses, and Social Workers

Nurse Practitioner Credit Designation

This activity is approved for 1.25 contact hours of continuing education (which includes .66 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20064303. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Registered Nursing Designation 

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.25 continuing education contact hours through the California Board of Registered Nursing.

Social Worker Designation 

The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/2020-12/10/2023. Social workers completing this course receive 1.25  continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1.25 CE clinical contact hours for this activity.

To view system requirements please go to https://llsce.org/system-requirements

For questions, grievances, or assistance with special needs (physical, etc.) please contact us atProfEducation@LLS.org .

Disclosure of Conflicts of Interest — All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. The faculty are also expected to disclose any unlabeled or investigational uses of any product(s) discussed in their presentations.

Faculty Disclosures

Sagar Lonial, MD, has nothing to disclose.

Kathryn Maples, PharmD, BCOP, has nothing to disclose.

Charise Gleason, has nothing to disclose.

Content/Peer Reviewer Disclosures

Felicia Williams, DNP, AOCNP, has nothing to disclose. 

Disclaimer — All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. The faculty are also expected to disclose any unlabeled or investigational uses of any product(s) discussed in their presentations.

Estimated time to complete activity: 1.25 hours
Date of initial release:  June 5, 2020
Valid for CE credit through: July 31, 2021
Speakers
Lonial
Sagar Lonial,  MD
Chair and Professor 
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine 
Atlanta, GA

Sagar Lonial, MD, is the Department Chair for Hematology and Medical Oncology at Emory University, and is the myeloma editor for Clinical Lymphoma and Myeloma and on the editorial board for the Journal of Clinical Oncology.  He is also an ad hoc reviewer for Blood, Cancer Research, Clinical Cancer Research, Haematologica, Leukemia, and other journals. He has authored or co-authored over 200 papers and abstracts.  He serves as Vice Chair of the Myeloma Committee in the Eastern Cooperative Oncology Group and as Chair of the Steering Committee for the Multiple Myeloma Research Consortium. Additionally, he is on the board of directors for the International Myeloma Society and on the scientific Advisory Board for the International Myeloma Foundation.

Dr. Lonial has worked in the field of immunotherapy and cancer, and has spent time developing the B-cell malignancy program with respect to novel targeted agents in laboratory models as well as early clinical trials. Dr. Lonial’s previous laboratory work has focused on evaluating the impact of purified dendritic cell subsets on the nature of immune responses against antigen.  Most recently, Dr. Lonial has focused on combinations of novel agents as therapy for myeloma and lymphoma, particularly evaluating combinations that may result in synergistic inhibition of the PI3-K/Akt pathway and the role of 14-3-3 in proteasome function.


Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute
Emory Healthcare
Atlanta, GA

Kathryn Maples, PharmD, BCOP, received her Doctor of Pharmacy from the University of Georgia College of Pharmacy in 2015.  She then completed her ASHP-accredited PGY1 Pharmacy Practice Residency and PGY2 Oncology Pharmacy Residency at Virginia Commonwealth University Health in Richmond, VA. Dr. Maples began her career as a clinical pharmacy specialist within the lymphoma/myeloma group at Memorial Sloan Kettering Cancer Center in August 2017, and joined Emory Winship Cancer Institute as a myeloma clinical specialist in June 2019.  She is board certified in oncology pharmacy and her professional interests include clinical research in multiple myeloma, hematopoietic cell transplantation, and survivorship support. 


Gleason
Charise Gleason, MSN, NP-BC, AOCNP®
Nurse Practitioner
Chief Advanced Practice Provider
Winship Cancer Institute
Emory University 
Adjunct Faculty 
Nell Hodgson Woodruff School of Nursing 
Atlanta, GA

Charise Gleason, MSN, NP-BC, AOCNP®, is a nurse practitioner in the Multiple Myeloma program at the Emory Winship Cancer Institute in Atlanta. She has been at Emory since 1998, when she started as a hematology/oncology nurse, and she joined the BMT program as a nurse practitioner in 2003. She is also adjunct faculty at the Nell Hodgson Woodruff School of Nursing at Emory University and chief Advanced Practice Provider for Winship Cancer Institute of Emory University. She earned both her bachelor’s and master’s degrees from Emory University, and holds an advanced oncology certification through the ONCC.

Ms. Gleason has been an active presenter and educator on the topics of multiple myeloma, plasma cell dyscrasias, survivorship, and side effect management, and is an active participant on the International Myeloma Foundation Nurse Leadership Board. She is also active in clinical research and has authored or co-authored many publications, including book chapters, abstracts, articles for nursing journals, and scientific publications.

Resources

Resources for HCPs

Online & In-person free CME & CE courses: www.LLS.org/CE

Treating Blood Cancers podcasts: www.LLS.org/HCPpodcast

Clinical Trials and Research

  • Clinical Trials: Learn more about clinical trials: LLS.org/ClinicalTrials
  • Research: Focused on finding cures, driving research in areas of unmet medical need, and bridging the gap between academic discovery & drug development: LLS.org/Research

Advocacy dedicated to removing barriers to care: www.LLS.org/Advocacy

Resources for Patients

MM Specific Resources – www.LLS.org/MM

Free Information Booklets:  www.LLS.org/Booklets

Telephone/Web Education Programs:  www.LLS.org/Programs

Videos: www.LLS.org/Educationvideos

Podcasts: www.LLS.org/LLS-podcast

Support Resources : www.LLS.org/Support

  • Financial Assistance
    • Co-Pay
    • Travel Assistance
    • Referral to Medication Access programs
  • Information Resource Center
  • LLS Chapters
  • LLS Community (social media platform)
  • Patti Robinson Kaufman First Connection Program (peer-to-peer)
  • One-On-One Nutrition Consultations (PearlPoint)

Information Resource Specialists: www.LLS.org/IRC

Assist through treatment, financial & social challenges, and give accurate treatment and support information. HCPs can also order free materials to distribute to patients.

Clinical Trial Support Center:  www.LLS.org/CTSC

Patients & caregivers work one-on-one with an LLS Clinical Trial Nurse Navigator who will help find clinical trials and personally assist throughout the clinical trial process, providing an additional resource to the HCP team.

  • Phone: (800) 955-4572, M-F, 9 am to 9 pm ET
  • Email: infocenter@LLS.org

Live chat: www.LLS.org/InformationSpecialists

If you have any questions, please contact us at  ProfEducation@LLS.org or call our Information Resource staff at 800-955-4572.

   

Course Content

MM Presentation
Post Activity Assessment [K20004MM]
Evaluation and Application for Credit [K20004MM]

Tags: KG20004_MM

Course Progress

0% Complete
0/2 Steps

Course Navigation

Course Home
MM Presentation
Post Activity Assessment [K20004MM]
Evaluation and Application for Credit [K20004MM]

Participant Type

2020 The Leukemia & Lymphoma Society
Login
Accessing this course requires a login, please enter your credentials below!

Forgot Password?
Lost Your Password?
Register
Don't have an account? Register one!
Register an Account

Registration confirmation will be emailed to you.